Breast Cancer Stages And Staging Before 2018 | Susan G. Komen®
Có thể bạn quan tâm
Breast cancer stage describes the extent of the cancer within your body.
Breast cancer stage is the most important factor for prognosis (chance of survival). In general, the earlier the stage, the better the prognosis will be.
If you were diagnosed before 2018, your breast cancer was staged a bit differently than it would be today.
Before 2018, stage was determined by 3 measures:
- Tumor size
- Lymph node status (the number and location of lymph nodes with cancer)
- Metastases (whether or not the cancer has spread to other areas of the body)
Starting in 2018, more measures have been used to classify stage.
If you were diagnosed before 2018, this page has information on how your breast cancer was staged.
No matter if you were staged before 2018 or since 2018, your breast cancer treatment was guided by the same factors including hormone receptor status and HER2 status.
Learn about breast cancer stages and staging since 2018.
Breast cancer staging
Pathologic staging is the standard way to stage breast cancer. It’s based on a pathologist’s study of the tumor tissue and any lymph nodes removed during surgery.
Clinical staging includes results from a health care provider’s physical exam, tests and/or imaging, such as mammography. Sometimes, these findings may add to the pathologist’s findings and may help with staging.
TNM system of staging for breast cancers diagnosed before 2018
The main method of pathologic staging for breast cancer is the TNM system.
TNM stands for:
- T = Tumor size
- N = Lymph Node status (the number and location of lymph nodes with cancer)
- M = Metastases (whether or not the cancer has spread to other areas of the body)
A “p” before the T or N shows these are pathology findings from the tumor or lymph nodes removed during surgery.
Before 2018, stage depended on the combination of just these 3 measures.
For detailed information on staging and tumor size, lymph node status and the presence or absence of metastases, click on the topics below.
Tumor Size and StagingTumor size is related to prognosis (chance of survival). In general, the smaller the tumor, the better prognosis tends to be.
A “T” followed by a number shows the size of the tumor. A diagnosis of carcinoma in situ (DCIS) is written as Tis.
In some cases, the size of the tumor cannot be determined (TX) or a tumor cannot be found (TO).
| Tumor size categories for breast cancers diagnosed before 2018 | |
| TX: Tumor size cannot be assessed | |
| T0: No tumor can be found | |
| Tis: Carcinoma in situ | |
| Subcategories of Tis: | |
| Tis (DCIS): Ductal carcinoma in situ (DCIS) | |
| Tis (LCIS): Lobular carcinoma in situ (LCIS) | |
| Tis (Paget): Paget disease of the breast (Paget disease of the nipple) with no DCIS, LCIS or invasive breast cancer | |
| T1: Tumor is 2 cm or smaller | |
| Subcategories of T1: | |
| T1mi: Very small tumor (0.1 cm or smaller) | |
| T1a: Tumor is larger than 0.1 cm, but no larger than 0.5 cm | |
| T1b: Tumor is larger than 0.5 cm, but no larger than 1 cm | |
| T1c: Tumor is larger than 1 cm, but no larger than 2 cm | |
| T2: Tumor is larger than 2 cm, but no larger than 5 cm | |
| T3: Tumor is larger than 5 cm | |
| T4: Tumor is any size, but has spread beyond the breast tissue to the chest wall and/or skin | |
| Subcategories of T4: | |
| T4a: Tumor has spread to the chest wall | |
| T4b: Tumor has spread to the skin, but is not inflammatory breast cancer | |
| T4c: Tumor has spread to both the chest wall and skin | |
| T4d: Inflammatory breast cancer | |
Learn more about tumor size.
Lymph Node Status and StagingLymph node status shows whether or not the axillary lymph nodes (the lymph nodes in the underarm area) contain cancer:
- Lymph node-negative means none of the axillary lymph nodes contain cancer.
- Lymph node-positive means at least one axillary lymph node contains cancer.
Prognosis (chance of survival) is better when cancer has not spread to the lymph nodes (lymph node-negative).
The more lymph nodes that contain cancer, the poorer the prognosis tends to be.
Find a 3D interactive model of the breast and lymph nodes.
How is lymph node status assessed?
A pathology exam is the best way to assess lymph node status. This is called pathologic lymph node status.
Usually, a surgeon removes one or more axillary lymph nodes with a technique called sentinel node biopsy. A pathologist studies these nodes under a microscope to see if they contain cancer.
A physical exam (also called a clinical exam) can give a first estimate of lymph node status. This is called clinical lymph node status. Enlarged lymph nodes can be a sign the breast cancer has spread to the lymph nodes.
Clinical lymph node status is only used when pathologic findings aren’t available.
In breast cancer staging, an “N” followed by a number and/or letters shows the lymph node status.
| Categories for breast cancers diagnosed before 2018 | ||
| Pathologic lymph node status | Clinical lymph node status(only used when pathologic findings are not available) | |
| NX | Axillary lymph nodes and other nearby lymph nodes cannot be assessed (for example, they were not removed during surgery) | Axillary lymph nodes and other nearby lymph nodes cannot be assessed (for example, they were removed in the past) |
| N0 | Axillary lymph nodes and other nearby lymph nodes don’t have cancer when looked at under a microscope | Axillary lymph nodes and other nearby lymph nodes don’t have cancer |
| N1 | Micrometastases (very small clusters of cancer) OR 1–3 axillary lymph nodes have cancer AND/OR Internal mammary nodes have cancer or micrometastases (very small clusters of cancer cells) found on sentinel node biopsy | Axillary lymph nodes have cancer, but can be moved around |
| N2 | 4–9 axillary lymph nodes have cancer OR Internal mammary nodes have cancer, but axillary lymph nodes don’t have cancer | Axillary lymph nodes have cancer and are matted together or fixed to other structures (such as the chest wall) OR Internal mammary nodes have cancer, but axillary lymph nodes don’t appear to have cancer |
| N3 | 10 or more axillary lymph nodes have cancer OR Infraclavicular (under the clavicle (collarbone)) nodes have cancer OR Internal mammary nodes have cancer plus 1 or more axillary lymph nodes have cancer OR 4 or more axillary lymph nodes have cancer plus internal mammary nodes have cancer or micrometastases found on sentinel node biopsy OR Supraclavicular (above the clavicle) nodes have cancer | Infraclavicular (under the clavicle) nodes have cancer (axillary lymph nodes may or may not have cancer) OR Internal mammary nodes and axillary lymph nodes have cancer OR Supraclavicular (above the clavicle) nodes have cancer (axillary lymph nodes may or may not have cancer) |
Learn more about lymph node status.
Learn more about assessing lymph nodes.
Metastases and StagingThe letter “M’ in the TNM breast cancer staging system shows the presence or absence of metastases.
Cancer has either spread beyond the breast and nearby lymph nodes to other parts of the body (M1) or it hasn’t (M0).
| MX | Metastases cannot be assessed |
| M0 | No metastases |
| M1 | Metastases |
Learn about treatment for metastatic breast cancer.
Stages of breast cancer diagnosed before 2018
The stages of breast cancer range from 0 to IV (0 to 4).
The highest stage (stage IV) is any breast cancer with metastases (M1), no matter the size of the tumor or the lymph node status. This is known as metastatic breast cancer and is the most advanced stage of disease.
Most often, the higher the stage of the cancer, the poorer the prognosis (chance of survival) will be.
The table below lists the TNM classifications (for breast cancer diagnosed before 2018) for each stage.
| Stages for breast cancer diagnosed before 2018 | |
| Ductal carcinoma in situ (DCIS) | |
| Stage 0 | TisN0M0 |
| Early breast cancer | |
| Stage Ia | T1N0M0 |
| Stage Ib | T0N1miM0 |
| T1N1miM0 | |
| Stage IIa | T0N1M0 |
| T1N1M0 | |
| T2N0M0 | |
| Locally advanced breast cancer | |
| Stage IIb | T2N1M0 |
| T3N0M0 | |
| Stage IIIa | T0N2M0 |
| T1N2M0 | |
| T2N2M0 | |
| T3N1M0 | |
| T3N2M0 | |
| Stage IIIb | T4N0M0 |
| T4N1M0 | |
| T4N2M0 | |
| Stage IIIc | Any T, N3M0 |
| Metastatic breast cancer | |
| Stage IV | Any T, any N, M1 |
Updated 03/05/25
This content is regularly reviewed by an expert panel including researchers, practicing clinicians and patient advocates.
Từ khóa » T2n0m0
-
Prognosis In T2N0M0 Stage I Breast Carcinoma: A 20-year Follow-up ...
-
Adjuvant Chemotherapy For Patients With T2N0M0 NSCLC - PMC
-
Cancer Staging - NCI
-
Prognostic Factors In The Patients With T2N0M0 Colorectal Cancer
-
Comparison Of T2N0M0 And T3aN0M0 In Predicting The Prognosis ...
-
Breast Cancer: Stages
-
Prognosis In T2N0M0 Stage I Breast Carcinoma: A ... - ASCO Journals
-
Survival Outcomes In Patients With T2N0M0 (Stage II) Squamous ...
-
Clinical Stage T1–T2N0M0 Oesophageal Cancer: Accuracy Of Clinical ...
-
T2N0M0 Esophageal Cancer
-
Who Are The Real High-risk Patients With Pathological T2N0M0 Non ...
-
3739 Cases From The National Cancer Data Base | SpringerLink
-
Table SI. Clinical Information Of The Lung Adenocarcinoma And ...